Arecor Therapeutics plc (LON:AREC – Get Free Report)’s stock price hit a new 52-week low on Wednesday . The company traded as low as GBX 47.95 ($0.62) and last traded at GBX 47.95 ($0.62), with a volume of 16492 shares. The stock had previously closed at GBX 49 ($0.63).
Arecor Therapeutics Trading Down 2.2 %
The company has a current ratio of 1.37, a quick ratio of 6.24 and a debt-to-equity ratio of 5.51. The company has a fifty day moving average of GBX 53.22 and a two-hundred day moving average of GBX 65.53. The stock has a market capitalization of £18.10 million, a price-to-earnings ratio of -1.69 and a beta of -0.18.
Arecor Therapeutics Company Profile
Arecor Therapeutics plc is a globally focused biopharmaceutical company transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying our innovative proprietary technology platform, Arestat™, we are developing an internal portfolio of proprietary products in diabetes and other indications, as well as working with leading pharmaceutical and biotechnology companies to deliver therapeutic products.
See Also
- Five stocks we like better than Arecor Therapeutics
- The How and Why of Investing in Gold Stocks
- Energy Transfer: Powering Data With Dividends and Diversification
- There Are Different Types of Stock To Invest In
- Qualcomm Stock Is Coiling for a Breakout
- Business Services Stocks Investing
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
